Skip to main content
. 2022 Jul 15;65(14):9662–9677. doi: 10.1021/acs.jmedchem.2c00704

Figure 6.

Figure 6

(A) Activity of 30 in NOD SCID mice bearing engineered Ba/F3 (EGFR L858R/T790M/C797S) tumors. (B) Activity of 30 in NOD SCID mice bearing engineered Ba/F3 (EGFR ex19del/T790M/C797S) tumors. (C) Activity of 30 and osimertinib in EGFR ex19del/T790M/C797S PDX model.